Genetic polymorphism of the C-reactive protein (CRP) gene and a deep infection focus determine maximal serum CRP level in Staphylococcus aureus bacteremia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 29, Issue 9, 2010, Pages 1131-1137

  Molkanen T ^a   Rostila, A ^b   Ruotsalainen, E ^a   Alanne, M ^b   Perola, M ^b   Jarvinen A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BACTEREMIA; CHEMISTRY; FEMALE; GENE FREQUENCY; GENETICS; HUMAN; LEUKOCYTOSIS; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PATHOGENICITY; PATHOLOGY; SERUM; SINGLE NUCLEOTIDE POLYMORPHISM; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADULT; AGED; BACTEREMIA; C-REACTIVE PROTEIN; FEMALE; GENE FREQUENCY; HUMANS; LEUKOCYTOSIS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SERUM; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 78349249443     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-010-0978-z     Document Type: Article

References (38)

1. Black S, Kushner I, Samols D (2004) C-reactive protein. J Biol Chem 279(47):48487-48490
2. Povoa P (2002) C-reactive protein: a valuable marker of sepsis. Intensive Care Med 28(3):235-243
3. Povoa P, Coelho L, Almeida E et al (2006) Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study. Crit Care 10(2):R63
4. Lobo SM, Lobo FR, Bota DP et al (2003) C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 123(6):2043-2049
5. Agrawal A, Suresh MV, Singh SK, Ferguson DA Jr (2008) The protective function of human C-reactive protein in mouse models of streptococcus pneumoniae infection. Endocr Metab Immune Disord Drug Targets 8(4):231-237
6. Pankow JS, Folsom AR, Cushman M et al (2001) Familial and genetic determinants of systemic markers of inflammation: The NHLBI family heart study. Atherosclerosis 154(3):681-689
7. Retterstol L, Eikvar L, Berg K (2003) A twin study of C-reactive protein compared to other risk factors for coronary heart disease. Atherosclerosis 169(2):279-282
8. MacGregor AJ, Gallimore JR, Spector TD, Pepys MB (2004) Genetic effects on baseline values of C-reactive protein and serum amyloid A protein: A comparison of monozygotic and dizygotic twins. Clin Chem 50(1):130-134
9. Woo P, Korenberg JR, Whitehead AS (1985) Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component. J Biol Chem 260(24):13384-13388
10. Walsh MT, Divane A, Whitehead AS (1996) Fine mapping of the human pentraxin gene region on chromosome 1q23. Immunogenetics 44(1):62-69
11. Hage FG, Szalai AJ (2007) C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol 50(12):1115-1122
12. Ridker PM, Pare G, Parker A et al (2008) Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the women's genome health study. Am J Hum Genet 82(5):1185-1192
13. Morita A, Nakayama T, Soma M (2006) Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. Am J Hypertens 19(6):593-600
14. Eklund C, Kivimaki M, Islam MS et al (2008) C-reactive protein genetics is associated with carotid artery compliance in men in the cardiovascular risk in young Finns study. Atherosclerosis 196(2):841-848
15. Zee RY, Germer S, Thomas A et al (2008) C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study. Atherosclerosis 197(2):931-936
16. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG (2008) Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 359(18):1897-1908
17. Roy S, Hill AV, Knox K, Griffiths D, Crook D (2002) Research pointers: association of common genetic variant with susceptibility to invasive pneumococcal disease. BMJ 324(7350):1369
18. Eklund C, Huttunen R, Syrjanen J, Laine J, Vuento R, Hurme M (2006) Polymorphism of the C-reactive protein gene is associated with mortality in bacteraemia. Scand J Infect Dis 38(11-12):1069-1073
19. Perry TE, Muehlschlegel JD, Liu KY et al (2009) C-reactive protein gene variants are associated with postoperative C-reactive protein levels after coronary artery bypass surgery. BMC Med Genet 10(1):38
20. Conterno LO, Wey SB, Castelo A (1998) Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 19(1):32-37
21. Soriano A, Martinez JA, Mensa J et al (2000) Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 30(2):368-373
22. Benfield T, Espersen F, Frimodt-Moller N et al (2007) Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 13(3):257-263
23. Mylotte JM, Tayara A (2000) Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 31(5):1170-1174
24. Fowler VG Jr, Olsen MK, Corey GR et al (2003) Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163(17):2066-2072
25. Fatkenheuer G, Preuss M, Salzberger B et al (2004) Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 23(3):157-162
26. Ruotsalainen E, Jarvinen A, Koivula I et al (2006) Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients. J Intern Med 259(2):179-190
27. Jackson GG, Arana-Sialer JA, Andersen BR, Grieble HG, McCabe WR (1962) Profiles of pyelonephritis. Arch Intern Med 110:63-75
28. Mermel LA, Farr BM, Sherertz RJ et al (2001) Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32(9):1249-1272
29. Ruotsalainen E, Sammalkorpi K, Laine J et al (2006) Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients. BMC Infect Dis 6:137
30. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Methodol 57(1):289-300
31. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265
32. Szalai AJ, Wu J, Lange EM et al (2005) Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med 83(6):440-447
33. Ruotsalainen E, Karden-Lilja M, Kuusela P et al (2008) Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: host factors, microbiological and serological characteristics. J Infect 56(4):249-256
34. Kovacs A, Green F, Hansson LO et al (2005) A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 178(1):193-198
35. Kathiresan S, Larson MG, Vasan RS et al (2006) Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 113(11):1415-23
36. Suk Danik J, Chasman DI, Cannon CP et al (2006) Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia. Ann Hum Genet 70(Pt 6):705-16
37. Ridker PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107(3):363-369
38. Wolford JK, Gruber JD, Ossowski VM et al (2003) A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Mol Genet Metab 78(2):136